Technical Analysis for ABLX - Ablynx NV

Grade Last Price % Change Price Change
grade C 41.63 -1.70% -0.72
ABLX closed down 1.7 percent on Friday, January 19, 2018, on 68 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Very Strong N/A Up Up
See historical ABLX trend table...

Date Alert Name Type % Chg
Jan 19 Calm After Storm Range Contraction 0.00%
Jan 19 Wide Bands Range Expansion 0.00%
Jan 19 Overbought Stochastic Strength 0.00%
Jan 18 Calm After Storm Range Contraction -1.70%
Jan 18 Wide Bands Range Expansion -1.70%
Jan 18 Gapped Up Strength -1.70%
Jan 18 Overbought Stochastic Strength -1.70%
Jan 17 1,2,3 Pullback Bullish Bullish Swing Setup 0.48%
Jan 17 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.48%
Jan 17 Calm After Storm Range Contraction 0.48%

Older signals for ABLX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Ablynx is dedicated to creating new medicines which will make a real difference to society. Today, the Company has more than 45 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease. Ablynx has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals.
Is ABLX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 45.77
52 Week Low 17.75
Average Volume 278,658
200-Day Moving Average 0.0
50-Day Moving Average 26.5164
20-Day Moving Average 32.2435
10-Day Moving Average 40.192
Average True Range 1.8273
ADX 55.89
+DI 55.92
-DI 10.39
Chandelier Exit (Long, 3 ATRs ) 40.2881
Chandelier Exit (Short, 3 ATRs ) 28.8119
Upper Bollinger Band 49.6418
Lower Bollinger Band 14.8452
Percent B (%b) 0.77
BandWidth 107.918185
MACD Line 5.1521
MACD Signal Line 4.1658
MACD Histogram 0.9863
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 43.33
Resistance 3 (R3) 43.39 42.88 43.04
Resistance 2 (R2) 42.88 42.45 42.85 42.95
Resistance 1 (R1) 42.26 42.18 42.01 42.20 42.85
Pivot Point 41.75 41.75 41.63 41.72 41.75
Support 1 (S1) 41.13 41.32 40.88 41.07 40.41
Support 2 (S2) 40.62 41.05 40.59 40.31
Support 3 (S3) 40.00 40.62 40.22
Support 4 (S4) 39.94